In a report by Fintel on May 24, 2023, Piper Sandler reaffirmed its coverage of Cooper Companies (NYSE:COO) with an Overweight recommendation.
Analysts forecast a 1.47% upside in the average one-year price target for COO, which is currently 383.52, with a range of 338.35 to $451.50. This forecast indicates an increase from the latest reported closing price of 377.97.
COO is projected to have an annual revenue of 3,522MM, an increase of 4.21%. The projected annual non-GAAP EPS is 12.75.
There are currently 1253 funds or institutions reporting positions in COO, which is a decrease of 6 owners or 0.48% from the last quarter. The average portfolio weight of all funds dedicated to COO is 0.30% which denotes a decrease of 16.64%. Total shares owned by institutions increased in the last three months by 0.02% to 57,316K shares.
The put/call ratio of COO is 0.32, indicating a bullish outlook.
The major shareholders of COO are Veritas Asset Management LLP with 2,089K shares or 4.22% ownership, followed by T. Rowe Price Investment Management with 1,984K shares or 4.01% ownership, Generation Investment Management Llp with 1,627K shares or 3.29% ownership, and Alliancebernstein with 1,566K shares representing 3.17% ownership. Kayne Anderson Rudnick Investment Management, holding 1,532K shares or 3.10% ownership is the only major shareholder to have increased its portfolio allocation in COO by 1.65% over the last quarter.
Cooper Companies is a global medical device company that operates through two business units, CooperVision and CooperSurgical. CooperVision develops a wide range of high-quality products for contact lens wearers and provides focused practitioner support, while CooperSurgical focuses on medical devices and fertility & genomics to advance the health of women, babies, and families.
For more information about companies with the largest price target upside, visit Fintel’s leaderboard of companies.
Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect those of Nasdaq, Inc.
